Abstract

Chronic Kidney Disease (CKD) represents a global health crisis, with profound implications for patients' quality of life and systems worldwide. Despite decades of research, treatment options for CKD have been limited, emphasizing healthcare symptom management and disease progression slowing rather than curative interventions. However, recent years have witnessed a surge of innovation and investment in drug development for kidney disease, offering renewed hope to patients and clinicians. This abstract provides a succinct overview of the latest advancements, challenges, and future prospects in drug development for kidney disease.